Automatic External Defibrillators for Public Access Defibrillation: Recommendations for Specifying and Reporting Arrhythmia Analysis Algorithm Performance, Incorporating New Waveforms, and Enhancing Safety
- 18 March 1997
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 95 (6) , 1677-1682
- https://doi.org/10.1161/01.cir.95.6.1677
Abstract
These recommendations are presented to enhance the safety and efficacy of AEDs intended for public access. The task force recommends that manufacturers present developmental and validation data on their own devices, emphasizing high sensitivity for shockable rhythms and high specificity for nonshockable rhythms. Alternative defibrillation waveforms may reduce energy requirements, reducing the size and weight of the device. The highest levels of safety for public access defibrillation are needed. Safe and effective use of AEDs that are widely available and easily handled by nonmedical personnel has the potential to dramatically increase survival from cardiac arrest.Keywords
This publication has 9 references indexed in Scilit:
- American Heart Association Report on the Public Access Defibrillation Conference December 8-10, 1994Circulation, 1995
- Comparison of monophasic and biphasic defibrillating pulse waveforms for transthoracic cardioversionThe American Journal of Cardiology, 1995
- Truncated Biphasic Pulses for Transthoracic DefibrillationCirculation, 1995
- Emergency Cardiac Care Committee and Subcommittees, American Heart AssociationPublished by American Medical Association (AMA) ,1992
- Increasing fibrillation duration enhances relative asymmetrical biphasic versus monophasic defibrillator waveform efficacy.Circulation Research, 1990
- Defibrillation of 100 kg calves with asymmetrical, bidirectional, rectangular pulsesCardiovascular Research, 1984
- Transthoracic Ventricular Defibrillation in the 100 kg Calf with Symmetrical One-Cycle Bidirectional Rectangular Wave StimuliIEEE Transactions on Biomedical Engineering, 1983
- “Proving the null hypothesis” in clinical trialsControlled Clinical Trials, 1982